While a common misconception about endometriosis is that it is simply a "menstruation disease," EndoFound says it's in fact a ...

First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...

Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

Ovarian cancer, often termed a 'silent killer,' is frequently diagnosed late due to subtle, easily dismissed early symptoms ...

SAN ANTONIO — Thanksgiving is a holiday that is centered around gatherings, including food, family, and friends. Meet the San ...

Secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves overall survival in ...

The FDA granted breakthrough therapy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, peritoneal or fallopian tube cancers. The FDA has accepted a new drug application ...

A gentle ache, a missed period, a feeling of being off; women often carry on through symptoms that could signal deeper ...

Salpingectomy for permanent contraception yields an incremental cost-effectiveness ratio of $143,769 per quality-adjusted ...